BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 39 filers reported holding BRIDGEBIO PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,858 | -15.3% | 6,110 | -30.4% | 0.47% | -24.9% |
| Q2 2023 | $6,920 | -36.8% | 8,785 | -40.6% | 0.63% | -32.0% |
| Q1 2023 | $10,956 | +38.9% | 14,785 | -13.2% | 0.92% | +59.4% |
| Q4 2022 | $7,890 | -99.9% | 17,035 | +3.0% | 0.58% | -11.9% |
| Q3 2022 | $9,736,000 | -10.6% | 16,535 | -17.5% | 0.66% | -15.9% |
| Q2 2022 | $10,895,000 | +10.6% | 20,035 | +21.5% | 0.78% | +21.7% |
| Q1 2022 | $9,850,000 | -6.9% | 16,489 | +13.6% | 0.64% | -22.5% |
| Q4 2021 | $10,578,000 | +53.1% | 14,515 | +190.3% | 0.83% | +17.0% |
| Q3 2021 | $6,911,000 | +110.1% | 5,000 | +150.0% | 0.71% | +131.5% |
| Q2 2021 | $3,290,000 | – | 2,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 141,500,000 | $63,675,000 | 2.13% |
| ARISTEIA CAPITAL, L.L.C. | 156,841,000 | $70,578,450 | 1.41% |
| Affinity Asset Advisors, LLC | 7,500,000 | $3,410,048 | 1.34% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $3,782,500 | 0.94% |
| TFG Asset Management GP Ltd | 10,000,000 | $4,623,611 | 0.66% |
| Context Capital Management, LLC | 17,035 | $7,890 | 0.58% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 47,329,000 | $18,813 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $2,287,850 | 0.32% |
| MACKAY SHIELDS LLC | 14,611,000 | $6,574,950 | 0.17% |
| Ionic Capital Management LLC | 1,400,000 | $644,740 | 0.15% |